Flunarizine related movement disorders: a nationwide population-based study

[1]  K. Abe.  Cerebral small vessel disease and incident parkinsonism: The RUN DMC study , 2016, Neurology.

[2]  Joseph Jankovic,et al.  The relationship between essential tremor and Parkinson's disease. , 2016, Parkinsonism & related disorders.

[3]  D. Norris,et al.  Cerebral small vessel disease and incident parkinsonism , 2015, Neurology.

[4]  P. Bugalho,et al.  Iatrogenic parkinsonism: the role of flunarizine and cinnarizine. , 2014, Journal of Parkinson's disease.

[5]  S. Chung,et al.  Drug-Induced Parkinsonism , 2012, Journal of clinical neurology.

[6]  H. Fernandez,et al.  Drug-induced parkinsonism , 2009, Current treatment options in neurology.

[7]  Bernard Perbal,et al.  Ten years later… , 2009, Journal of Cell Communication and Signaling.

[8]  M. Muckenthaler,et al.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. , 2009, Journal of Alzheimer's disease : JAD.

[9]  G. Thaker,et al.  Ethnicity and the Course of Tardive Dyskinesia in Outpatients Presenting to the Motor Disorders Clinic at the Maryland Psychiatric Research Center , 2004, Journal of clinical psychopharmacology.

[10]  G. Fabiani,et al.  Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine. , 2004, Arquivos de neuro-psiquiatria.

[11]  Lorene M Nelson,et al.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. , 2003, American journal of epidemiology.

[12]  A. Negrotti,et al.  Cinnarizine‐induced parkinsonism: Ten years later , 1999, Movement disorders : official journal of the Movement Disorder Society.

[13]  J. Martí-Massó,et al.  Cinnarizine‐induced parkinsonism: Ten years later , 1998, Movement Disorders.

[14]  A. Negrotti,et al.  A long‐term follow‐up study of cinnarizine‐ and flunarizine‐induced parkinsonism , 1997, Movement disorders : official journal of the Movement Disorder Society.

[15]  F. Jiménez-Jiménez,et al.  Drug-induced parkinsonism in a movement disorders unit: A four-year survey. , 1996, Parkinsonism & related disorders.

[16]  L. Deecke,et al.  D2 Receptor Blockade by Flunarizine and Cinnarizine Explains Extrapyramidal Side Effects. A SPECT Study , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  A. Negrotti,et al.  Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility. , 1992, Neurotoxicology.

[18]  S Giménez-Roldán,et al.  Cinnarizine-induced parkinsonism. Susceptibility related to aging and essential tremor. , 1991, Clinical neuropharmacology.

[19]  F. Micheli,et al.  Movement disorders and depression due to flunarizine and cinnarizine , 1989, Movement disorders : official journal of the Movement Disorder Society.

[20]  J. Jass,et al.  A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCER , 1987, The Lancet.

[21]  F. Micheli,et al.  Flunarizine‐ and cinnarizine‐induced extrapyramidal reactions , 1987, Neurology.

[22]  R. Meyboom,et al.  PARKINSONISM, TARDIVE DYSKINESIA, AKATHISIA, AND DEPRESSION INDUCED BY FLUNARIZINE , 1986, The Lancet.

[23]  Sara Romero,et al.  PARKINSONISM, TARDIVE DYSKINESIA, AKATHISIA, AND DEPRESSION INDUCED BY FLUNARIZINE , 1986, The Lancet.

[24]  J. M. Martí Massó,et al.  [Parkinsonism possibly caused by cinnarizine]. , 1985, Medicina clínica (Ed. impresa).